Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pharmacokinetics in vivo and pharmacodynamics ex vivo/in vitro of meropenem and cefpirome in the Yucatan micropig model: continuous infusion versus intermittent.

Similar presentations


Presentation on theme: "Pharmacokinetics in vivo and pharmacodynamics ex vivo/in vitro of meropenem and cefpirome in the Yucatan micropig model: continuous infusion versus intermittent."— Presentation transcript:

1 Pharmacokinetics in vivo and pharmacodynamics ex vivo/in vitro of meropenem and cefpirome in the Yucatan micropig model: continuous infusion versus intermittent injection  Hassan Elkhaïli, Jean-Daniel Peter, Davide Pompei, Dominique Levěque, Laurence Linger, Yves Salmon, Julie Salmon, Henri Monteil, François Jehl  Clinical Microbiology and Infection  Volume 4, Issue 1, Pages (January 1998) DOI: /j tb00329.x Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

2 Figure 1 Relationship between ISB (see text) and meropenem concentrations for E. cloacae after 4 h of contact. Clinical Microbiology and Infection 1998 4, 18-26DOI: ( /j tb00329.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

3 Figure 2 Bactericidal activity against E. cloacae (6-h exposure) of micropig serum diluted to 1/2 versus time profiles following administration of meropenem by intravenous short infusion and continuous infusion. Clinical Microbiology and Infection 1998 4, 18-26DOI: ( /j tb00329.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

4 Figure 3 Bactericidal activity against K. pneumoniae (6 h exposure) of micropig serum diluted to 1/2 versus time profiles following administration of meropenem by intravenous short infusion and continuous infusion. Clinical Microbiology and Infection 1998 4, 18-26DOI: ( /j tb00329.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

5 Figure 4 Relationship between ISB and cefpirome concentrations for S. aureus after 4 h (A) and 8 h (B) of contact. Clinical Microbiology and Infection 1998 4, 18-26DOI: ( /j tb00329.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

6 Figure 5 Relationship between ISB and cefpirome concentrations for E. cloacae after 6 h of contact. Clinical Microbiology and Infection 1998 4, 18-26DOI: ( /j tb00329.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions


Download ppt "Pharmacokinetics in vivo and pharmacodynamics ex vivo/in vitro of meropenem and cefpirome in the Yucatan micropig model: continuous infusion versus intermittent."

Similar presentations


Ads by Google